Cargando…
993. Combining Key Residues of the Russian and US Live-Attenuated Influenza Viruses for a More Attenuated Virus
BACKGROUND: The Live Attenuated Influenza Virus (LAIV) used in the United States is based on the cold-passaged A/AnnArbor/6/60 strain (AA). An alternative LAIV (Len), developed from the cold-passaged A/Leningrad/134/17/57 strain, has also been used in some countries outside the United States. Recent...
Autores principales: | Smith, Andrew, Rodriguez-Garcia, Laura, Ghouayel, Maya El, Martinez-Sobrido, Luis, Dewhurst, Stephen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253618/ http://dx.doi.org/10.1093/ofid/ofy210.830 |
Ejemplares similares
-
A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus
por: Smith, Andrew, et al.
Publicado: (2020) -
Development of a novel equine influenza virus live-attenuated vaccine
por: Rodriguez, Laura, et al.
Publicado: (2018) -
A Bivalent Live-Attenuated Vaccine for the Prevention of Equine Influenza Virus
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019) -
A New Master Donor Virus for the Development of Live-Attenuated Influenza B Virus Vaccines
por: White, Chantelle L., et al.
Publicado: (2021) -
Generation and Characterization of Live Attenuated Influenza A(H7N9) Candidate Vaccine Virus Based on Russian Donor of Attenuation
por: Shcherbik, Svetlana, et al.
Publicado: (2015)